Publication: 4071

Publication: 4071

Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Int J Radiat Oncol Biol Phys vol 120 (1) 111-9

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 14

Parents:: 3424
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA189850, UG1CA232760, UG1CA233180, UG1CA233290, UG1CA233329; 1U24CA180803 (IROC); U10CA180868 (NRG Oncology)

Corr. Author:
Authors:: Leila T. Tchelebi Diana Segovia Koren Smith Qian Shi TJ Fitzgerald Michael D. Chuong Tyler J. Zemla Eileen M. O'Reilly Jeffrey Meyerhardt Eugene J. Koay Jessica Lowenstein Ardaman Shergill Matthew HG Katz Joseph M. Herman

Networks:: LAPS-IL057, LAPS-MA036, LAPS-NY016, LAPS-TX035, MD015, NORTHWELL

Study: Alliance-A021501
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: